ENDLESS
DEAD

Serial Number

90464300

Owner

SAIL BIOMEDICINES, INC.

Attorney

Christina M. Licursi

Filing Date

Jan 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ENDLESS Trademark

Serial Number: 90464300

ENDLESS is a trademark filed by SAIL BIOMEDICINES, INC. on January 13, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SAIL BIOMEDICINES, INC. (8 trademarks)

140 First Street, Suite 601
CAMBRIDGE, MA 02141

Entity Type: 03

Laronde, Inc. (4 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

January 13, 2021

Registration Date

Not Registered

Published for Opposition

May 31, 2022

Goods & Services

Pharmaceutical preparations for gene therapy; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders

Testing, inspection, research, and development of pharmaceutical preparations for gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 29, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 29, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 7, 2025 EXRA
SOU EXTENSION 5 GRANTED
Oct 6, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 6, 2025 AITU
SOU TEAS EXTENSION RECEIVED
May 22, 2025 EEXT
SOU EXTENSION 5 FILED
May 21, 2025 EXT5
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 24, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 24, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 24, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 26, 2024 EX4G
SOU EXTENSION 4 FILED
Nov 26, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 26, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2024 EXRA
SOU EXTENSION 3 GRANTED
May 29, 2024 EX3G
SOU EXTENSION 3 FILED
May 29, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
May 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 16, 2023 EXRA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 15, 2023 ASGN
SOU EXTENSION 2 GRANTED
Nov 14, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 14, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 14, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2023 EXRA
SOU EXTENSION 1 GRANTED
Apr 27, 2023 EX1G
SOU EXTENSION 1 FILED
Apr 27, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 27, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
NEW NOA TO ISSUE
Oct 17, 2022 NEWN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 28, 2022 NOAM
NOTICE OF ALLOWANCE CANCELLED
Jul 26, 2022 IUCN
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 31, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 11, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 28, 2022 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2022 CRFA
ASSIGNED TO LIE
Apr 20, 2022 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 18, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 1, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 1, 2021 GNFR
FINAL REFUSAL WRITTEN
Nov 1, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 4, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 4, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 4, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2021 NWOS